Das Kurzdarmsyndrom in Deutschland

Objective

As data about prevalence and standard of care in short bowel syndrome (SBS) are not available for Germany, this study estimated the prevalence and assessed the medical infrastructure to potentially improve care of SBS patients.

Methods

In a validated approach for prevalence estimation in rare diseases, a randomized census of 478 size-stratified hospitals with surgical, internal medicine and pediatric departments was conducted to estimate SBS prevalence. The number of SBS patients, specialized outpatient clinics and caregiver expertise were assessed.

Results

The response rate was 85?% of randomized hospitals (405/478). Strata-derived estimation yielded a total of 2,808 SBS patients in Germany for 2011/2012 (95?% CI: 1750.3865), translating into a prevalence estimation for 34/million inhabitants (95?% CI: 21.47). Overall expertise in SBS treatment was only rated “satisfactory” by most caregivers. While 86 specialized outpatient clinics were identified, there was no central registry to access these resources.

Conclusion

Short bowel syndrome, with a newly estimated prevalence of 34/million inhabitants is not a very rare medical condition in Germany. The interdisciplinary approach needed for optimal care for SBS patients would be greatly facilitated by a central registry.